These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 35579711)
1. Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis. Pan J; Li W; Gu L; Liu C; Zhang K; Hong G Eur Radiol; 2022 Nov; 32(11):7883-7895. PubMed ID: 35579711 [TBL] [Abstract][Full Text] [Related]
2. LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI. Song JS; Choi EJ; Hwang SB; Hwang HP; Choi H Eur Radiol; 2019 Jan; 29(1):401-410. PubMed ID: 29922928 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies. Li J; Wang J; Lei L; Yuan G; He S Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172 [TBL] [Abstract][Full Text] [Related]
4. Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features? Joo I; Lee JM; Lee DH; Jeon JH; Han JK Eur Radiol; 2019 Apr; 29(4):1724-1732. PubMed ID: 30255250 [TBL] [Abstract][Full Text] [Related]
5. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma. Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783 [TBL] [Abstract][Full Text] [Related]
6. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis. Li X; Li C; Wang R; Ren J; Yang J; Zhang Y PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904 [TBL] [Abstract][Full Text] [Related]
7. Do transition and hepatobiliary phase hypointensity improve LI-RADS categorization as an alternative washout: a systematic review and meta-analysis. Pan J; Tao Y; Chi X; Yang L; Zhao Y; Chen F Eur Radiol; 2022 Aug; 32(8):5134-5143. PubMed ID: 35267090 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid-enhanced MRI. Huang P; Wu F; Hou K; Zhou C; Xiao Y; Wang C; Miao G; Yang C; Zeng M Eur Radiol; 2024 Apr; 34(4):2271-2282. PubMed ID: 37792079 [TBL] [Abstract][Full Text] [Related]
9. Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5 Auer TA; Halskov S; Fehrenbach U; Nevermann NF; Pelzer U; Mohr R; Hamm B; Schöning W; Horst D; Ihlow J; Geisel D Eur Radiol; 2023 Oct; 33(10):6902-6915. PubMed ID: 37115216 [TBL] [Abstract][Full Text] [Related]
10. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI. Kim YN; Song JS; Moon WS; Hwang HP; Kim YK Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310 [TBL] [Abstract][Full Text] [Related]
11. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma. Chen CY; Chen J; Xia CC; Huang ZX; Song B J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310 [TBL] [Abstract][Full Text] [Related]
12. An improved diagnostic algorithm for subcentimeter hepatocellular carcinoma on gadoxetic acid-enhanced MRI. Huang P; Zhou C; Wu F; Xiao Y; Qian X; Wang Y; Yang C; Zeng M Eur Radiol; 2023 Apr; 33(4):2735-2745. PubMed ID: 36472696 [TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis. Suh CH; Kim KW; Kim GY; Shin YM; Kim PN; Park SH Eur Radiol; 2015 Apr; 25(4):950-60. PubMed ID: 25537979 [TBL] [Abstract][Full Text] [Related]
14. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules. Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242 [TBL] [Abstract][Full Text] [Related]
15. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study. Kim SS; Kim SH; Song KD; Choi SY; Heo NH J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483 [TBL] [Abstract][Full Text] [Related]
16. Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta-analysis. Liu X; Jiang H; Chen J; Zhou Y; Huang Z; Song B Liver Transpl; 2017 Dec; 23(12):1505-1518. PubMed ID: 28886231 [TBL] [Abstract][Full Text] [Related]
17. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity. Wu JW; Yu YC; Qu XL; Zhang Y; Gao H World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings. Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131 [TBL] [Abstract][Full Text] [Related]
19. Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients. Phongkitkarun S; Limsamutpetch K; Tannaphai P; Jatchavala J World J Gastroenterol; 2013 Dec; 19(45):8357-65. PubMed ID: 24363528 [TBL] [Abstract][Full Text] [Related]
20. Liver imaging reporting and data system diagnostic performance in hepatocellular carcinoma when modifying the definition of "washout" on gadoxetic acid-enhanced magnetic resonance imaging. Hu W; Lyu R; Wang D; Gao Z; Sun C; Jia K Arab J Gastroenterol; 2024 Feb; 25(1):58-63. PubMed ID: 38245474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]